Clobazam and Taxotere drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Clobazam (clobazam) and Taxotere (docetaxel). Common drug interactions include white blood cell count decreased among females.

The phase IV clinical study analyzes what interactions people have when they take Clobazam and Taxotere. It is created by eHealthMe based on reports of 29 people who take the same drugs from the FDA, and is updated regularly.

What is Clobazam?

Clobazam has active ingredients of clobazam. eHealthMe is studying from 14,399 Clobazam users. Check the latest studies of Clobazam.

What is Taxotere?

Taxotere has active ingredients of docetaxel. It is often used in breast cancer. eHealthMe is studying from 62,513 Taxotere users. Check the latest studies of Taxotere.

On Aug, 11, 2026

29 people who take Clobazam and Taxotere together, and have interactions are studied.

Clobazam and Taxotere drug interactions.

What are the common drug interactions of Clobazam and Taxotere, by gender? *:

female:

White blood cell count decreased
Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures)
Hemianopia (blindness or reduction in vision in one half of the visual field due to damage of the optic pathways in the brain)
Nausea (feeling of having an urge to vomit)
Thrombocytopenia (decrease of platelets in blood)
Pneumonia
Skin fissures (a crack in the skin)
Dehydration (dryness resulting from the removal of water)
Headache (pain in head)
Cataract (clouding of the lens inside the eye)

male:

n/a

What are the common drug interactions of Clobazam and Taxotere, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Skin fissures (a crack in the skin)
Thrombocytopenia (decrease of platelets in blood)
Cataract (clouding of the lens inside the eye)
Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures)
Pneumonia
White blood cell count decreased
Hemianopia (blindness or reduction in vision in one half of the visual field due to damage of the optic pathways in the brain)
Nausea (feeling of having an urge to vomit)

40-49:

Hemianopia (blindness or reduction in vision in one half of the visual field due to damage of the optic pathways in the brain)
White blood cell count decreased
Thrombocytopenia (decrease of platelets in blood)
Nausea (feeling of having an urge to vomit)
Skin fissures (a crack in the skin)

50-59:

n/a

60+:

n/a

What are the existing conditions these people have? *

Fainting (loss of consciousness and postural tone): 18 people, 62.07%
Cataract (clouding of the lens inside the eye): 16 people, 55.17%
Nausea (feeling of having an urge to vomit): 11 people, 37.93%
Diarrhea: 11 people, 37.93%
Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 10 people, 34.48%
Headache (pain in head): 9 people, 31.03%
Sleep Disorder: 8 people, 27.59%
Depression: 6 people, 20.69%
Breast Cancer Metastatic: 6 people, 20.69%
Spinal Pain (pain in spine): 3 people, 10.34%

* Approximation only. Some reports may have incomplete information.

Do you take Clobazam and Taxotere?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously